Skip to main content
Premium Trial:

Request an Annual Quote

Lumera and MUSC Sign Protein Array Development Pact

NEW YORK, Feb. 6 (GenomeWeb News) - Lumera and the Medical University of South Carolina have signed a co-development agreement, Lumera said today.

 

Under the deal, MUSC researchers will work with Lumera to co-develop a new protein array based on Lumera's NanoCapture HPT technology.

 

In addition, MUSC has committed to buying Lumera's ProteomicProcessor biosensor instrument.

 

Lumera retains the commercial rights to all jointly developed intellectual property, Lumera said.

 

No further details were provided.

The Scan

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.